Market News

Maxim Group Reaffirms $53.0000 Target Price On QCR Holdings (QCRH), Reaffirms Buy Rating; Nanthealth (NH) Sellers Increased By 4.42% Their Shorts

Research analysts at Maxim Group have $53.0000 target on QCR Holdings (NASDAQ:QCRH). Maxim Group’s target would suggest a potential upside of 18.75% from the company’s last stock close. The rating was shown in a research note on 18 April.

Nanthealth Inc (NASDAQ:NH) had an increase of 4.42% in short interest. NH’s SI was 2.34M shares in April as released by FINRA. Its up 4.42% from 2.24M shares previously. With 118,000 avg volume, 20 days are for Nanthealth Inc (NASDAQ:NH)’s short sellers to cover NH’s short positions. The SI to Nanthealth Inc’s float is 12.48%. The stock increased 0.92% or $0.03 during the last trading session, reaching $3.29. About 53,012 shares traded. NantHealth, Inc. (NASDAQ:NH) has declined 35.53% since April 18, 2017 and is downtrending. It has underperformed by 47.08% the S&P500.

Among 5 analysts covering Nant Health (NASDAQ:NH), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Nant Health had 5 analyst reports since June 27, 2016 according to SRatingsIntel. FBR Capital initiated the shares of NH in report on Monday, June 27 with “Outperform” rating. First Analysis initiated the stock with “Overweight” rating in Monday, June 27 report. The stock has “Outperform” rating by Cowen & Co on Monday, June 27. The firm earned “Buy” rating on Monday, June 27 by Jefferies. The stock of NantHealth, Inc. (NASDAQ:NH) earned “Buy” rating by Canaccord Genuity on Monday, June 27.

NantHealth, Inc. operates as an evidence personalized healthcare company. The company has market cap of $356.56 million. The firm engages in converging science and technology through an integrated clinical platform to provide health information at the point of care for critical illnesses. It currently has negative earnings. It develops NantHealth solutions, an adaptive learning system, including molecular profiling solution, software, middleware, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from novel and traditional sources to enhance decision-making.

Investors sentiment decreased to 1.55 in Q4 2017. Its down 0.82, from 2.37 in 2017Q3. It dropped, as 12 investors sold QCR Holdings, Inc. shares while 26 reduced holdings. 16 funds opened positions while 43 raised stakes. 8.35 million shares or 1.89% more from 8.19 million shares in 2017Q3 were reported. Citadel Advsr Limited Com holds 22,414 shares. The New York-based Millennium Mgmt has invested 0.01% in QCR Holdings, Inc. (NASDAQ:QCRH). Schwab Charles Invest holds 0% or 54,827 shares in its portfolio. 431,079 were reported by Endicott Management. Manufacturers Life Insurance The reported 0.01% of its portfolio in QCR Holdings, Inc. (NASDAQ:QCRH). Parametric Port Assocs Limited Liability Corp accumulated 7,638 shares or 0% of the stock. 21,870 are owned by Bridgeway Capital Management. Shell Asset Mgmt reported 15,470 shares. Ajo Limited Partnership reported 126,136 shares or 0.02% of all its holdings. Bnp Paribas Arbitrage Sa reported 3,559 shares. The Japan-based Asset One has invested 0% in QCR Holdings, Inc. (NASDAQ:QCRH). Systematic Mngmt Limited Partnership stated it has 0.02% of its portfolio in QCR Holdings, Inc. (NASDAQ:QCRH). 93,253 were accumulated by Emerald Mutual Fund Advisers Tru. Oberweis Asset Mngmt holds 14,200 shares or 0.14% of its portfolio. Bessemer Gru holds 10,400 shares.

Since December 14, 2017, it had 1 buying transaction, and 5 selling transactions for $296,226 activity. 1,021 shares valued at $45,332 were sold by HELLING LARRY J on Tuesday, December 19. 2,014 shares valued at $89,285 were sold by HULTQUIST DOUGLAS M on Wednesday, February 28. $6,555 worth of stock was bought by Ziegler Marie Z. on Friday, January 19. BUDD THOMAS D sold 997 shares worth $44,200. 800 shares valued at $34,584 were sold by BAIRD PATRICK on Friday, December 15.

Among 7 analysts covering QCR Holdings (NASDAQ:QCRH), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. QCR Holdings has $56.0 highest and $33 lowest target. $50.67’s average target is 13.55% above currents $44.625 stock price. QCR Holdings had 19 analyst reports since September 2, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained QCR Holdings, Inc. (NASDAQ:QCRH) rating on Tuesday, October 3. Keefe Bruyette & Woods has “Buy” rating and $52.0 target. The company was maintained on Thursday, December 21 by Keefe Bruyette & Woods. Maxim Group maintained QCR Holdings, Inc. (NASDAQ:QCRH) on Monday, October 31 with “Buy” rating. As per Monday, February 5, the company rating was maintained by Stephens. On Friday, October 6 the stock rating was maintained by Piper Jaffray with “Buy”. Piper Jaffray initiated the shares of QCRH in report on Thursday, October 6 with “Overweight” rating. On Friday, June 9 the stock rating was maintained by Keefe Bruyette & Woods with “Buy”. The firm has “Buy” rating given on Friday, November 3 by Maxim Group. Maxim Group maintained the stock with “Buy” rating in Monday, December 19 report. The rating was maintained by Maxim Group with “Buy” on Friday, February 2.

The stock increased 0.39% or $0.175 during the last trading session, reaching $44.625. About 139,937 shares traded or 171.89% up from the average. QCR Holdings, Inc. (NASDAQ:QCRH) has risen 6.12% since April 18, 2017 and is uptrending. It has underperformed by 5.43% the S&P500.

QCR Holdings, Inc. (NASDAQ:QCRH) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *